Thermo Fisher Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Thermo Fisher Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TMO

Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. Thermo Fisher Scientific serves customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial, research and development, quality and process control settings. 

CEO
Marc N. Casper
CEOMarc N. Casper
Employees
125,000
Employees125,000
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
1956
Founded1956
Employees
125,000
Employees125,000

TMO Key Statistics

Market cap
175.88B
Market cap175.88B
Price-Earnings ratio
27.56
Price-Earnings ratio27.56
Dividend yield
0.35%
Dividend yield0.35%
Average volume
2.25M
Average volume2.25M
High today
$498.82
High today$498.82
Low today
$471.83
Low today$471.83
Open price
$489.00
Open price$489.00
Volume
1.59M
Volume1.59M
52 Week high
$643.99
52 Week high$643.99
52 Week low
$385.46
52 Week low$385.46

Stock Snapshot

With a market cap of 175.88B, Thermo Fisher Scientific(TMO) trades at $473.36. The stock has a price-to-earnings ratio of 27.56 and currently yields dividends of 35.2%.

On 2026-03-27, Thermo Fisher Scientific(TMO) stock traded between a low of $471.83 and a high of $498.82. Shares are currently priced at $473.36, which is +0.3% above the low and -5.1% below the high.

The Thermo Fisher Scientific(TMO)'s current trading volume is 1.59M, compared to an average daily volume of 2.25M.

In the last year, Thermo Fisher Scientific(TMO) shares hit a 52-week high of $643.99 and a 52-week low of $385.46.

In the last year, Thermo Fisher Scientific(TMO) shares hit a 52-week high of $643.99 and a 52-week low of $385.46.

TMO News

TipRanks 12h
Thermo Fisher initiated with a Buy at DZ Bank

DZ Bank initiated coverage of Thermo Fisher (TMO) with a Buy rating and $610 price target Published first on TheFly – the ultimate source for real-time, market...

Simply Wall St 1d
Is It Time To Reassess Thermo Fisher Scientific After Recent Share Price Weakness?

If you are wondering whether Thermo Fisher Scientific at around US$490 per share is pricing in too much optimism or not enough, this article breaks down what th...

Is It Time To Reassess Thermo Fisher Scientific After Recent Share Price Weakness?
TipRanks 2d
Thermo Fisher Scientific: Early Clario Close Enhances 2026 Growth Outlook and AI-Driven Competitive Position, Supporting Buy Rating

Thermo Fisher, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Michael Ryskin from Bank of America Securities maintaine...

Analyst ratings

90%

of 29 ratings
Buy
89.7%
Hold
10.3%
Sell
0%

More TMO News

TipRanks 3d
Thermo Fisher Completes Strategic Acquisition of Clario Holdings

Thermo Fisher ( (TMO) ) just unveiled an announcement. On March 24, 2026, Thermo Fisher Scientific announced it had completed the $8.875 billion cash acquisiti...

People also own

Based on the portfolios of people who own TMO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.